{"text": ["Bristol-Myers", "Squibb\u2019s", "Oncology", "Portfolio", "in", "4Q17"], "created_at": "2018-02-12 22:05:08"}
{"text": ["Regeneron", "Could", "Benefit", "From", "&apos;Lackluster&apos;", "Data", "Presented", "By", "These", "Rivals"], "created_at": "2018-02-12 21:26:32"}
{"text": ["Pfizer\u2019s", "Bosulif", "Had", "a", "Strong", "Performance", "in", "4Q17", "and", "2017"], "created_at": "2018-02-12 19:10:02"}
{"text": ["Pfizer\u2019s", "Inlyta:", "Analyzing", "Revenue", "Trends"], "created_at": "2018-02-12 17:40:02"}
{"text": ["Greek", "PM", "wants", "politicians", "investigated", "in", "alleged", "Novartis", "bribery", "case"], "created_at": "2018-02-12 16:39:22"}
{"text": ["Greek", "PM", "wants", "politicians", "investigated", "in", "alleged", "Novartis", "bribery", "case"], "created_at": "2018-02-12 16:32:09"}
{"text": ["Can", "Jakafi", "Performance", "Drive", "Incyte's", "(INCY)", "Q4", "Earnings?"], "created_at": "2018-02-12 16:11:29"}
{"text": ["Can", "Jakafi", "Performance", "Drive", "Incyte's", "(INCY)", "Q4", "Earnings?"], "created_at": "2018-02-12 16:11:29"}
{"text": ["How\u2019s", "Pfizer\u2019s", "Oncology", "Business", "Positioned", "after", "2017?"], "created_at": "2018-02-12 16:06:47"}
{"text": ["Cardinal", "Health", "a", "Top", "Ranked", "SAFE", "Dividend", "Stock", "With", "2.8%", "Yield", "(CAH)"], "created_at": "2018-02-12 14:06:25"}
{"text": ["Cardinal", "Health", "a", "Top", "Ranked", "SAFE", "Dividend", "Stock", "With", "2.8%", "Yield", "(CAH)"], "created_at": "2018-02-12 14:06:25"}
{"text": ["Why", "Novartis\u2019s", "Entresto", "Could", "Witness", "a", "Robust", "Demand", "Trend", "in", "2018"], "created_at": "2018-02-12 14:04:46"}
{"text": ["What", "Could", "Drive", "Amgen\u2019s", "Long-Term", "Growth?"], "created_at": "2018-02-12 14:01:27"}
{"text": ["How", "Much", "Profit", "Should", "Novartis", "Earn", "By", "Curing", "A", "Childhood", "Leukemia?"], "created_at": "2018-02-12 13:03:00"}
{"text": ["What\u2019s", "Expected", "of", "Novartis\u2019s", "Net", "Profit", "Margin", "in", "2018?"], "created_at": "2018-02-12 12:37:08"}
{"text": ["The", "Swiss", "Stock", "Market", "Starts", "The", "Week", "With", "A", "Gain"], "created_at": "2018-02-12 12:12:00"}
{"text": ["The", "Swiss", "Stock", "Market", "Starts", "The", "Week", "With", "A", "Gain"], "created_at": "2018-02-12 12:12:00"}
{"text": ["European", "Markets", "Recover", "Some", "Lost", "Ground"], "created_at": "2018-02-12 11:55:00"}
{"text": ["European", "Markets", "Recover", "Some", "Lost", "Ground"], "created_at": "2018-02-12 11:55:00"}
{"text": ["GlaxoSmithKline", "plc", "--", "Moody's:", "M&A", "greatest", "downside", "risk", "to", "European", "pharma", "companies'", "credit", "quality", "in", "2018"], "created_at": "2018-02-12 10:31:08"}
{"text": ["European", "Shares", "Rebound", "From", "Six-month", "Lows"], "created_at": "2018-02-12 06:09:00"}
{"text": ["European", "Shares", "Rebound", "From", "Six-month", "Lows"], "created_at": "2018-02-12 06:09:00"}
{"text": ["Better", "Buy:", "Pfizer", "Inc.", "(PFE)", "vs.", "Eli", "Lilly", "(LLY)"], "created_at": "2018-02-12 05:06:16"}
{"text": ["Better", "Buy:", "Pfizer", "Inc.", "(PFE)", "vs.", "Eli", "Lilly", "(LLY)"], "created_at": "2018-02-12 05:06:16"}
